Literature DB >> 26720468

Choroideremia Is a Systemic Disease With Lymphocyte Crystals and Plasma Lipid and RBC Membrane Abnormalities.

Alice Yang Zhang1, Naveen Mysore1, Hojatollah Vali2, Jamie Koenekoop3, Sang Ni Cao3, Shen Li3, Huanan Ren3, Vafa Keser3, Irma Lopez-Solache3, Sorath Noorani Siddiqui1, Ayesha Khan1, Jeannie Mui4, Kelly Sears4, Jim Dixon5, Jeremy Schwartzentruber6, Jacek Majewski6, Nancy Braverman7, Robert K Koenekoop1.   

Abstract

PURPOSE: Photoreceptor neuronal degenerations are common, incurable causes of human blindness affecting 1 in 2000 patients worldwide. Only half of all patients are associated with known mutations in over 250 disease genes, prompting our research program to identify the remaining new genes. Most retinal degenerations are restricted to the retina, but photoreceptor degenerations can also be found in a wide variety of systemic diseases. We identified an X-linked family from Sri Lanka with a severe choroidal degeneration and postulated a new disease entity. Because of phenotypic overlaps with Bietti's crystalline dystrophy, which was recently found to have systemic features, we hypothesized that a systemic disease may be present in this new disease as well.
METHODS: For phenotyping, we performed detailed eye exams with in vivo retinal imaging by optical coherence tomography. For genotyping, we performed whole exome sequencing, followed by Sanger sequencing confirmations and cosegregation. Systemic investigations included electron microscopy studies of peripheral blood cells in patients and in normal controls and detailed fatty acid profiles (both plasma and red blood cell [RBC] membranes). Fatty acid levels were compared to normal controls, and only values two standard deviations above or below normal controls were further evaluated.
RESULTS: The family segregated a REP1 mutation, suggesting choroideremia (CHM). We then found crystals in peripheral blood lymphocytes and discovered significant plasma fatty acid abnormalities and RBC membrane abnormalities (i.e., elevated plasmalogens). To replicate our discoveries, we expanded the cohort to nine CHM patients, genotyped them for REP1 mutations, and found the same abnormalities (crystals and fatty acid abnormalities) in all patients.
CONCLUSIONS: Previously, CHM was thought to be restricted to the retina. We show, to our knowledge for the first time, that CHM is a systemic condition with prominent crystals in lymphocytes and significant fatty acid abnormalities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26720468      PMCID: PMC4699407          DOI: 10.1167/iovs.14-15751

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  The metabolism of fatty acids in human Bietti crystalline dystrophy.

Authors:  J Lee; X Jiao; J F Hejtmancik; M Kaiser-Kupfer; W A Gahl; T C Markello; J Guo; G J Chader
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

2.  A histopathologic study of a choroideremia carrier.

Authors:  J G Flannery; A C Bird; D B Farber; R G Weleber; D Bok
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-02       Impact factor: 4.799

3.  Cloning of a gene that is rearranged in patients with choroideraemia.

Authors:  F P Cremers; D J van de Pol; L P van Kerkhoff; B Wieringa; H H Ropers
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

Review 4.  Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.

Authors:  J A van den Hurk; M Schwartz; H van Bokhoven; T J van de Pol; L Bogerd; A J Pinckers; E M Bleeker-Wagemakers; I H Pawlowitzki; K Rüther; H H Ropers; F P Cremers
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

5.  REP-2, a Rab escort protein encoded by the choroideremia-like gene.

Authors:  F P Cremers; S A Armstrong; M C Seabra; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

6.  Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa.

Authors:  E J Schaefer; S J Robins; G M Patton; M A Sandberg; C A Weigel-DiFranco; B Rosner; E L Berson
Journal:  J Lipid Res       Date:  1995-07       Impact factor: 5.922

Review 7.  Choroideremia: new findings from ocular pathology and review of recent literature.

Authors:  Ian M MacDonald; Laurie Russell; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2009 May-Jun       Impact factor: 6.048

8.  Investigational methods for peroxisomal disorders.

Authors:  Steven Steinberg; Richard Jones; Carol Tiffany; Ann Moser
Journal:  Curr Protoc Hum Genet       Date:  2008-07

9.  Rab GTPase prenylation hierarchy and its potential role in choroideremia disease.

Authors:  Monika Köhnke; Christine Delon; Marcus L Hastie; Uyen T T Nguyen; Yao-Wen Wu; Herbert Waldmann; Roger S Goody; Jeffrey J Gorman; Kirill Alexandrov
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  7 in total

1.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

2.  Molecular Characterization of Choroideremia-Associated Deletions Reveals an Unexpected Regulation of CHM Gene Transcription.

Authors:  Tiziana Fioretti; Valentina Di Iorio; Barbara Lombardo; Francesca De Falco; Armando Cevenini; Fabio Cattaneo; Francesco Testa; Lucio Pastore; Francesca Simonelli; Gabriella Esposito
Journal:  Genes (Basel)       Date:  2021-07-22       Impact factor: 4.096

3.  Progress in the development of novel therapies for choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Maria I Patrício; Robert E MacLaren
Journal:  Expert Rev Ophthalmol       Date:  2019-12-26

4.  REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia.

Authors:  Dulce Lima Cunha; Rose Richardson; Dhani Tracey-White; Alessandro Abbouda; Andreas Mitsios; Verena Horneffer-van der Sluis; Panteleimon Takis; Nicholas Owen; Jane Skinner; Ailsa A Welch; Mariya Moosajee
Journal:  JCI Insight       Date:  2021-05-10

5.  A comprehensive comparison of multilocus association methods with summary statistics in genome-wide association studies.

Authors:  Zhonghe Shao; Ting Wang; Jiahao Qiao; Yuchen Zhang; Shuiping Huang; Ping Zeng
Journal:  BMC Bioinformatics       Date:  2022-08-30       Impact factor: 3.307

Review 6.  Molecular Therapies for Choroideremia.

Authors:  Jasmina Cehajic Kapetanovic; Alun R Barnard; Robert E MacLaren
Journal:  Genes (Basel)       Date:  2019-09-23       Impact factor: 4.096

7.  Autofluorescence of choroidal vessels in Bietti's crystalline dystrophy.

Authors:  Hossein Ameri; Erin Su; Tyler J Dowd-Schoeman
Journal:  BMJ Open Ophthalmol       Date:  2020-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.